Pharmaceuticals

June 19, 2017

OWC Pharmaceuticals Engages CFN Media to Cultivate New Investor Audience & Communicate …

CFN Media will leverage its extensive reach and presence with mainstream and cannabis-focused investors and media across North America to ……

Read More

June 8, 2017

Bas Rutten Believes In A Future Without Pharmaceuticals Thanks To Marijuana And CBD

As he puts an addiction to oxycontin behind him thanks to CBD oil, we discussed athlete recovery without pharmaceuticals, getting over “legal…

Read More

Bas Rutten Believes In A Future Without Pharmaceuticals Thanks To Marijuana And CBD

While marijuana benefits a large swath of medical conditions, athletes are becoming far more overt in their usage of cannabidiol (CBD) oil…

Read More

June 5, 2017

Why the MGC Pharmaceuticals Ltd share price rocketed 21% today

Last Thursday the medicinal cannabis company placed its shares in a trading … research with MGC for all strains of CBD and…

Read More

June 2, 2017

Better Know a Marijuana Stock: Zynerba Pharmaceuticals

However, there are dozens of marijuana stocks for investors to choose from. … For those who may not recall, an oral CBD-based…

Read More

May 24, 2017

CBD VS. Pharmaceuticals: How Do They Compare?

There is still plenty more to be studied on this wondrous plant, yet studied did find that cannabis compounds, like CBD, have…

Read More

May 20, 2017

GW Pharmaceuticals – Cannabis Cannabinoid

GWPH's lead cannabinoid pharmaceutical product is Epidiolex. It is described as "a liquid formulation of pure plant-derived cannabidiol", CBD, which ……

Read More

April 6, 2017

Rich Pharmaceuticals announces Industry Veteran to Join CannCodex

Currently serving as a founding Chairman of the Cannabis LAB, Los … and development of non-traditional treatment methods involving CBD and THC….

Read More

March 22, 2017

InMed Pharmaceuticals Is More Than Just Another Cannabis Drug Company

Most medical marijuana processors are using THC and CBD because they are easy to extract in a large volume from the plant,…

Read More

February 23, 2017

Maxim Group Starts Zynerba Pharmaceuticals (ZYNE) at Buy

2017 could be a transformational year for Zynerba, as three ongoing phase II trials for lead cannabis-based candidate, ZYN002 cannabidiol (CBD) gel ……

Read More

February 19, 2017

Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) One of the More Legit Marijuana Companies

ZYN002 CBD gel is the first and only patent-protected, synthetic CBD that is formulated as a permeation-enhanced gel for transdermal delivery….

Read More

February 14, 2017

Cannabics Pharmaceuticals Inc (OTCMKTS:CNBX) Updates On Commercialization Of CBD

Dr. Eyal Ballan, who is the Chief scientist of Cannabics, reported that they intend to make use of the natural medicinal properties…

Read More